TWA
VIR icon

TCI Wealth Advisors’s Vir Biotechnology VIR Stock Holding History

TCI Wealth Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-149
Closed -$3.47K – 2167
2023
Q1 		$3.47K Sell
149
-92
-38% -$2.35K ﹤0.01% 1769
2022
Q4 		$6.1K Sell
241
-122
-34% -$2.99K ﹤0.01% 1395
2022
Q3 		$7K Buy
363
+133
+58% +$3.38K ﹤0.01% 1300
2022
Q2 		$6K Hold
230
– – ﹤0.01% 1420
2022
Q1 		$6K Buy
230
+105
+84% +$3.11K ﹤0.01% 1473
2021
Q4 		$5K Buy
125
+5
+4% +$196 ﹤0.01% 1730
2021
Q3 		$5K Buy
120
+57
+90% +$2.47K ﹤0.01% 1664
2021
Q2 		$3K Buy
63
+4
+7% +$182 ﹤0.01% 1865
2021
Q1 		$3K Buy
+59
New +$3.18K ﹤0.01% 1602

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return